Stork G, Uyeo S, Wakamatsu T, Grieco P, Labovitz J (1971). "Total synthesis of lupeol". Journal of the American Chemical Society. 93 (19): 4945. doi:10.1021/ja00748a068.
Surendra K, Corey EJ (October 2009). "A short enantioselective total synthesis of the fundamental pentacyclic triterpene lupeol". Journal of the American Chemical Society. 131 (39): 13928–9. doi:10.1021/ja906335u. PMID19788328.
Geetha T, Varalakshmi P (June 2001). "Anti-inflammatory activity of lupeol and lupeol linoleate in rats". Journal of Ethnopharmacology. 76 (1): 77–80. doi:10.1016/S0378-8741(01)00175-1. PMID11378285.
Nigam N, Prasad S, Shukla Y (November 2007). "Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin". Food and Chemical Toxicology. 45 (11): 2331–5. doi:10.1016/j.fct.2007.06.002. PMID17637493.
Saleem M, Afaq F, Adhami VM, Mukhtar H (July 2004). "Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice". Oncogene. 23 (30): 5203–14. doi:10.1038/sj.onc.1207641. PMID15122342.
Bani S, Kaul A, Khan B, Ahmad SF, Suri KA, Gupta BD, Satti NK, Qazi GN (April 2006). "Suppression of T lymphocyte activity by lupeol isolated from Crataeva religiosa". Phytotherapy Research. 20 (4): 279–87. doi:10.1002/ptr.1852. PMID16557610. S2CID34485412.
Margareth B. C. Gallo; Miranda J. Sarachine (2009). "Biological activities of Lupeol"(PDF). International Journal of Biomedical and Pharmaceutical Sciences. 3 (Special Issue 1): 46–66. Archived from the original(PDF) on 2010-10-25.
Surendra K, Corey EJ (October 2009). "A short enantioselective total synthesis of the fundamental pentacyclic triterpene lupeol". Journal of the American Chemical Society. 131 (39): 13928–9. doi:10.1021/ja906335u. PMID19788328.
Geetha T, Varalakshmi P (June 2001). "Anti-inflammatory activity of lupeol and lupeol linoleate in rats". Journal of Ethnopharmacology. 76 (1): 77–80. doi:10.1016/S0378-8741(01)00175-1. PMID11378285.
Nigam N, Prasad S, Shukla Y (November 2007). "Preventive effects of lupeol on DMBA induced DNA alkylation damage in mouse skin". Food and Chemical Toxicology. 45 (11): 2331–5. doi:10.1016/j.fct.2007.06.002. PMID17637493.
Saleem M, Afaq F, Adhami VM, Mukhtar H (July 2004). "Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice". Oncogene. 23 (30): 5203–14. doi:10.1038/sj.onc.1207641. PMID15122342.
Bani S, Kaul A, Khan B, Ahmad SF, Suri KA, Gupta BD, Satti NK, Qazi GN (April 2006). "Suppression of T lymphocyte activity by lupeol isolated from Crataeva religiosa". Phytotherapy Research. 20 (4): 279–87. doi:10.1002/ptr.1852. PMID16557610. S2CID34485412.
Bani S, Kaul A, Khan B, Ahmad SF, Suri KA, Gupta BD, Satti NK, Qazi GN (April 2006). "Suppression of T lymphocyte activity by lupeol isolated from Crataeva religiosa". Phytotherapy Research. 20 (4): 279–87. doi:10.1002/ptr.1852. PMID16557610. S2CID34485412.
Margareth B. C. Gallo; Miranda J. Sarachine (2009). "Biological activities of Lupeol"(PDF). International Journal of Biomedical and Pharmaceutical Sciences. 3 (Special Issue 1): 46–66. Archived from the original(PDF) on 2010-10-25.